Sunday, December 1, 2013

VERY INTERESTING INFORMATION: Doping Problem In Horseracing Denied By Trainers

Thoroughbred racing’s drug problem was a myth, representatives of the horseracing industry recently told the U.S. Congress. Phil Hanrahan, the chief executive officer of the National Horsemen’s Benevolent and Protective Association, told Congress members that bringing in the United States Anti-Doping Agency to clean up the sport was addressing a problem that does not exist. However, a report by the California Horse Racing Board revealed that Bob Baffert, a Hall of Fame trainer, revealed on the same day that the trainer had been administering a thyroid hormone to every horse in his barn without ever checking to see if any of them had thyroid problems.
The California Horse Racing Board report revealed that thyroxine, the drug, was so routinely prescribed in the barn of Bob Baffert that it was dispensed for one of the horses a week after he had died. This report was made after an investigation was conducted by the California Horse Racing Board into the sudden deaths of seven horses trained by Baffert from 2011 to 2013. The report of the board found no evidence that California Horse Racing Board rules or regulations have been violated. In the meanwhile, Baffert declined to answer why he gave thyroxine to every horse in his barn if he did not know if the drug was required by the horses. The trainer wrote on Twitter, “I’m gratified that C.H.R.B. completed its investigation & found there was no wrongdoing.”
The report revealed that Baffert acknowledged directing his veterinarians to use the drug on all his horses. It was also disclosed that it was the trainer who asked his veterinarians to prescribe it, which is in conflict with the policy of the American Association of Equine Practitioners, the industry’s most influential veterinary group. According to the American Association of Equine Practitioners, treatments should be based upon a specific diagnosis and administered in the context of a valid and transparent owner-trainer-veterinarian relationship.
The investigators were told by Baffert that he believed the drug would help “build up” horses at his barn. The trainer remarked he stopped administering thyroxine to his horses after the seventh horse died last March. The CHRB report said thyroxine can cause “cardiac alterations” in horses according to one study. C.H.R.B.’s equine medical director, Dr. Rick Arthur, summarizing his report to the board that he had no conclusive explanation of how seven horses belonging to one trainer dropped dead during a period of sixteen months. He added that it is extremely abnormal statistically and went on to say that it does say there is something wrong here despite the fact that we couldn’t find anything.
In another development, three thoroughbred trainers (David Wells, Sam Webb, and Patricia Anne Rogers) were arrested and charged in federal court a day after a congressional hearing on doping in horse racing. The three trainers have accused of devising a scheme to defraud those betting on thoroughbred races at Penn National Race Course in Grantville by administering banned substances to horses within 24 hours of a race. If convicted, they face up to 20 years in prison and a $250,000 fine.
quoted from here

Rep seeks tough pharmacy watch --Massachusetts predicts it will have the model legislaton for the rest of the states; IACP “IACP supports state efforts to strengthen oversight and inspection of compounding pharmacies,” the IACP said in the statement. “We also seek to ensure that states commit adequate resources to state oversight agencies, which the Massachusetts legislation does.”

December 1, 2013

Massachusetts lawmakers must step up in the face of lax federal oversight to protect patients from contaminated drugs, which last year spawned a deadly fungal meningitis outbreak linked to a Framingham compounding pharmacy, according to a state legislator leading the charge for tougher laws.
“We went in with the understanding that we were going to be on a heavier hook than the feds,” said state Rep. Jeffrey Sanchez (D-Jamaica Plain), chairman of the Joint Committee on Public Health. “This just confirms it.”
President Obama signed a compounding pharmacy bill into law last week, but the federal legislation lacks any real oversight because it calls for large-scale compounding pharmacies to register on a voluntary basis with the FDA for inspections.
Tainted steroid injections from the now-shuttered New England Compounding Center have been blamed for the fungal meningitis outbreak that killed 64 people and infected 751 others in 20 states.
Sanchez, who soon will head into a conference committee to sort out differences between his House bill and a Senate version, said he has high hopes lawmakers will hammer out a deal to protect patients.
“When we come out with the bill I feel confident that we will be able to get at this so it doesn’t happen again. The problem with NECC was ... there was no reporting protocol,” Sanchez said. “If something happens like what happened with NECC and you get sick, you’ll be able to contact someone.”
State lawmakers also pumped more than $1 million into this year’s budget to hire more regulators for surprise inspections, 
Sanchez said.
The International Academy of Compounding Pharmacists released a statement saying the group does not believe a voluntary approach protects the public.
“IACP supports state efforts to strengthen oversight and inspection of compounding pharmacies,” the IACP said in the statement. “We also seek to ensure that states commit adequate resources to state oversight agencies, which the Massachusetts legislation does.”
Sanchez said he’s not feeling pressure from lobbyists to radically alter the legislation, which could come up for a vote in January.
“I think there is a general acceptance and understanding that change is coming relative to compounding pharmacies,” Sanchez said. “This bill was set up as one of the toughest in the country. We’ll come out with a model that can be used for the rest of the country.”
quoted from here

Illinois Board of Pharmacy September 2013 Meeting Minutes Approved

read here

Illinois Board of Pharmacy Recent Disciplinary Action


PHARMACY
Jenae Dodd, Terre Haute, IN
– pharmacy technician license (049-198563) placed
in refuse to renew status for pleading guilty to felon
y retail theft after diverting controlled
substances, non-prescription substances, and United
States currency from her former employer.
Doretta Fitzpatrick, Norridge
– pharmacy technician license (049-091714) placed
in refuse to renew status due to unprofessional conduct
 related to diverting a controlled substance
from an Osco pharmacy's controlled substance invent
ory for the purpose of self medication.
Melany Laird, DeKalb
– pharmacy technician license (049-170296) placed
in a refuse to renew status due to being found guilty of Unlawful Possession of a Controlled Substance, a
Class 4 Felony, after admitting to diverting a larg
e volume of controlled substances from her
former employer.
Christina Pallack, Normal
– pharmacy technician license (049-203939) revoked
afterthe Department received information that she was te
rminated from her employment for theft.
Robert Blanford, Frisco, TX
– pharmacist license (051-290940) placed in refuse
to renew status after being disciplined by the state of Texas. 

quoted from here

Idaho Board of Pharmacy Compounding Rules Draft